Target volumes in radiotherapy for high-grade malignant glioma of the brain.
about
The evolving roles and controversies of radiotherapy in the treatment of glioblastomaIDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literatureWhat is the most appropriate clinical target volume for glioblastoma?Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation.A clinical interactive technique for MR-CT image registration for target delineation of intracranial tumors.Diagnostics of cerebral gliomas with radiolabeled amino acids.Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma.Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review.Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of gliomaAdvances in neuro-oncology imaging.Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.Personalized treatment strategies in glioblastoma: MGMT promoter methylation status.Novel membrane-permeable contrast agent for brain tumor detection by MRIMultifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literature.Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.Advances in radiotherapy: from 2D to 4D.Current challenges in clinical target volume definition: tumour margins and microscopic extensions.Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods.Amino acid PET and MR perfusion imaging in brain tumours.Multicentric spinal cord and brain glioblastoma without previous craniotomy.External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain.Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.Addition of magnetic resonance imaging to computed tomography-based three-dimensional conformal radiotherapy planning for postoperative treatment of astrocytomas: Changes in tumor volume and isocenter shift.Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.What is the best way to evaluate clinical target volume for radiotherapy of brain tumors?Radiation treatment parameters for re-irradiation of malignant glioma.Survival improvements with adjuvant therapy in patients with glioblastoma.Diffusion tensor magnetic resonance imaging driven growth modeling for radiotherapy target definition in glioblastoma.The impact of computed tomography slice thickness on the assessment of stereotactic, 3D conformal and intensity-modulated radiotherapy of brain tumors.Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study.Clinical evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online patient setup verification - A step towards MRI-based treatment planning.
P2860
Q26746622-5A3BD7A0-CA40-457C-997E-B6707ED9ADD6Q28075869-1C234CA4-5832-4199-8DBF-BAE8CA67DFB3Q30838129-E7A7697A-9751-4F93-B4F3-42853109D593Q31120167-5DE80F05-CF8B-44F5-A989-F067FE3148D3Q33215161-3E0D13CE-298C-4514-8C36-488BAEEA291FQ33487194-A2CF9B85-E3B9-46CD-BB67-E0B0CABE7F26Q33642508-E0B09560-D3B4-4E39-BEA0-1BF47C574D5CQ35177942-F07E1E3E-86E4-462B-8FAF-217760D19857Q36071865-72FCA451-DD4C-4CDA-B9E1-AC6371567C1AQ36339461-0206FBE6-4ED4-451E-833B-04B801F0E41AQ37037922-D785AA7B-68EA-4FD4-BE87-1F917C957FA4Q37098119-635291B0-2E1D-43B9-9CF3-C98BBDE9D414Q37221207-A3BEFE7D-0F76-459A-A99D-86C8DC182ABAQ37284164-6CB3D0CE-3933-42A5-804D-0647E6D0EC58Q37408026-7743EB05-54E8-440A-B28C-018023FC0AEEQ37455074-A975AD45-1685-442D-9944-55AC4F0FB5B7Q37850500-034E426D-64CE-41C9-82E1-65C69F9E21B7Q37970192-FDC51C35-1F1C-42FA-8CE8-B8000DABA8B2Q38045432-0DB150EA-0745-4059-9EAD-E23FB721F46CQ38269839-0A2B0E3A-1B2F-4706-B700-D0D2370DFD48Q38691946-A9D9B9A2-B2A2-467A-9D41-11AF8EB373B2Q38924520-D1AC0C7C-9D9A-4343-B38E-B65B0E3991C1Q39670061-0642FC4C-5419-4C89-963B-AD4FDD7C10D7Q42041284-9294E66A-E762-4F5B-9245-08F9DBD6112FQ42968374-9176DF50-73F4-4F72-808F-C5DFD94DCCA9Q43743749-AA64F405-6BA8-4DD9-96E7-AE7223AC026FQ44288866-FEAAA9CB-3064-4242-BBF5-B840514195B1Q46154560-DB85F910-C01C-4671-838A-D2B291909EE1Q47267204-42CAB5F9-5CBE-4234-BA3A-1D9662001D70Q48118589-92EB82C1-F581-4AD8-970F-0C40F7FD0EC3Q49012148-4A55A418-55F5-457E-AD33-6EE54E87FF96Q54977184-173D0BDD-6B68-4765-BF07-1DA1018434F2Q55461270-BFF31AB1-663D-4BA7-9959-08DC70A713ABQ55463865-7F81083F-C507-46D4-AA9D-22845AC7EA0C
P2860
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@ast
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@en
type
label
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@ast
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@en
prefLabel
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@ast
Target volumes in radiotherapy for high-grade malignant glioma of the brain.
@en
P2093
P1476
Target volumes in radiotherapy for high-grade malignant glioma of the brain
@en
P2093
E P Jansen
H Bartelink
P304
P356
10.1016/S0167-8140(00)00216-4
P577
2000-08-01T00:00:00Z